| Net Cash Provided by (Used in) Operating Activities |
$52,479,000 |
USD |
228% |
Q1 2025 |
FY 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$36,114,000 |
USD |
-35% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$6,050,000 |
USD |
-73% |
Q1 2025 |
FY 2025 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
35,130,000 |
shares |
0.99% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$102,601,000 |
USD |
4.4% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$3,217,000 |
USD |
-23% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$14,545,000 |
USD |
-32% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$27,000 |
USD |
1250% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$134,035,000 |
USD |
73% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$163,000 |
USD |
70% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$5,289,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$816,000 |
USD |
-90% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$274,000 |
USD |
21% |
Q1 2025 |
Q1 2025 |